No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics

Human Psychopharmacology

Volumn 27, Issue 1, 2012, Pages 82-89

  Yasui Furukori, Norio ^a   Fujii, Akira ^a   Sugawara, Norio ^a   Tsuchimine, Shoko ^a   Saito, Manabu ^a   Hashimoto, Kojiro ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

prolactin; schizophrenia; sex hormone; sexual dysfunction

Indexed keywords

ARIPIPRAZOLE; ESTRADIOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; RISPERIDONE; TESTOSTERONE;

AMENORRHEA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FEMALE; GALACTORRHEA; GYNECOMASTIA; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MENORRHAGIA; MULTICENTER STUDY; ORGASM DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SEXUAL AROUSAL; SEXUAL DYSFUNCTION; SIDE EFFECT; VAGINAL DRYNESS;

ADULT; ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROLACTIN; REGRESSION ANALYSIS; SCHIZOPHRENIA; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; YOUNG ADULT;

EID: 84856349294     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1275     Document Type: Article

References (32)

1. Aizenberg D, Zemishlany Z, Dorfman-Etrog P, et al,. 1995. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 56: 137-141.
2. Baldwin DS, Birtwistle J,. 1998. The side effect burden associated with drug treatment of panic disorder. J Clin Psychiatry 59 (Suppl 8): 39-44.
3. Barnes TRE, Harvey CA,. 1993. Psychiatric drugs and sexuality. In Sexual Pharmacology, Riley AJ, Peet M, Wilson C, (eds). Oxford Medical Publications: Oxford; 176-196.
4. Chiba S, Takahashi M,. 2005. The Japanese version of UKU side effect rating scale and the translation process. Jpn J Clin PsychoPharmacol 8: 193-196. (in Japanese)
5. Cutler AJ,. 2003. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 28 (Suppl 1): 69-82. (Pubitemid 36015662)
6. Fakhoury WK, Wright D, Wallace M,. 2001. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol 16: 153-162. (Pubitemid 32402360)
7. Fujii A, Yasui-Furukori N, Sugawara N, et al,. 2010. Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 34: 288-293.
8. Ghadirian AM, Chouinard G, Annable L,. 1982. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 170: 463-467. (Pubitemid 12051650)
9. Gopalakrishnan R, Jacob KS, Kuruvilla A, et al,. 2006. Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial. Am J Psychiatry 163: 494-499. (Pubitemid 44469393)
10. Howes OD, Wheeler MJ, Pilowsky LS, et al,. 2007. Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. J Clin Psychiatry 68: 361-367. (Pubitemid 46506799)
11. Hummer M, Kemmler G, Kurz M, et al,. 1999. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 156: 631-633. (Pubitemid 29162987)
12. Kinon BJ, Ahl J, Liu-Seifert H, et al,. 2006. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. Psychoneuroendocrinology 31: 577-588.
13. Kleinberg DL, Davis JM, de Coster R, et al,. 1999. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 19: 57-61. (Pubitemid 29047332)
14. Knegtering H, van der Moolen AE, Castelein S, et al,. 2003. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 28 (Suppl 2): 109-123. (Pubitemid 36335820)
15. Kotin J, Wilbert DE, Verburg D, et al,. 1976. Thioridazine and sexual dysfunction. Am J Psychiatry 133: 82-85.
16. Lingjaerde O, Ahlfors UG, Bech P, et al,. 1987. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 334: 1-100. (Pubitemid 17115352)
17. Madhusoodanan S, Parida S, Jimenez C,. 2010. Hyperprolactinemia associated with psychotropics-a review. Hum Psychopharmacol 25: 281-297.
18. Meaney AM, Smith S, Howes OD, et al,. 2004. Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br J Psychiatry 184: 503-508. (Pubitemid 38725710)
19. Moreira ED, Jr, Hartmann U, Glasser DB, et al,. 2005a. A population survey of sexual activity, sexual dysfunction and associated help-seeking behavior in middle-aged and older adults in Germany. Eur J Med Res 10: 434-443. (Pubitemid 41614703)
20. Moreira ED, Jr, Brock G, Glasser DB, et al,. 2005b. Help-seeking behaviour for sexual problems: the global study of sexual attitudes and behaviors. Int J Clin Pract 59: 6-16. (Pubitemid 40260106)
21. Moreira ED, Jr, Kim SC, Glasser D, et al,. 2006. Sexual activity, prevalence of sexual problems, and associated help-seeking patterns in men and women aged 40-80 years in Korea: data from the Global Study of Sexual Attitudes and Behaviors (GSSAB). J Sex Med 3: 201-211.
22. Olfson M, Uttaro T, Carson WH, et al,. 2005. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry 66: 331-338. (Pubitemid 40476756)
23. Patel AG, Mukherji K, Lee A,. 1996. Priapism associated with psychotropic drugs. Br J Hosp Med 55: 315-319.
24. Petty RG,. 1999. Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 35: S67-S73. (Pubitemid 29133027)
25. Pollack MH, Reiter S, Hammerness P,. 1992. Genitourinary and sexual adverse effects of psychotropic medication. Int J Psychiatry Med 22: 205-227.
26. Pompili M, Serafini G, Del Casale A, et al,. 2009. Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk. Expert Rev Neurother 9: 985-1004.
27. Rubin RT,. 1987. Prolactin and schizophrenia. In Psychopharmacology: The third generation of progress, Meltzer HY, (ed.). Raven Press: New York; 803-808.
28. Schwartz MF, Bauman JE, Masters WH,. 1982. Hyperprolactinemia and sexual disorders in men. Biol Psychiatry 17: 861-876. (Pubitemid 12046063)
29. Seeman P,. 2002. Atypical antipsychotics: mechanism of action. Can J Psychiatry 47: 27-38. (Pubitemid 34302921)
30. Segraves RT,. 1989. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 46: 275-284. (Pubitemid 19078265)
31. Smith SM, O'Keane V, Murray R,. 2002. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181: 49-55. (Pubitemid 34717838)
32. Valevski A, Modai I, Zbarski E, Zemishlany Z, Weizman A,. 1998. Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients. Clin Neuropharmacol 21: 355-357. (Pubitemid 28543952)